Patent Euroasia ready for national registration

No Comments

EuroAsia patents 2108550EA has been granted. The SensoDetects main portfolio is approved in the Euroasia (Armenia, Azerbaijan, Belarus, Kyrgyzstan, Kazakhstan, Moldova, Russia, Tajikistan and Turkmenistan) area. IP portfolio strenghtens through this in especially one very important market, Russia.   In these countries, there is similar problems in Psychiatry as in the rest of the world.

View Full Post

Proof of the methodology

No Comments

The technology from SensoDetect has been proven through research. A recent blind study at Uppsala University Hospital published in 2017, using SensoDetect technology concluded “The ABR profiling tests discriminated schizophrenia and ADHD versus healthy controls with high sensitivity and specificity”. For further reading, go to AktieTorget.

×

Make an appointment and we’ll contact you.

Translate »